The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serreze, D. V.
Right arrow Articles by Leiter, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serreze, D. V.
Right arrow Articles by Leiter, E. H.

The Journal of Immunology, Vol 147, Issue 4 1222-1229, Copyright © 1991 by American Association of Immunologists


ARTICLES

Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium

DV Serreze and EH Leiter
Jackson Laboratory, Bar Harbor, ME 04609.

Diabetes is a T cell-mediated process in NOD/Lt mice, with a major genetically recessive component of susceptibility linked to homozygous expression of the unique H-2g7 MHC haplotype. Heterozygous expression of the H-2nb1 haplotype derived from the NON/Lt strain confers diabetes resistance both in (NOD x NON)F1 hybrids and in NOD mice congenic for the H-2nb1 haplotype. However, diabetes resistance is abrogated in F1 hybrids by NOD/Lt bone marrow reconstitution. To establish whether the generation of beta cell autoreactive T cells from NOD/Lt bone marrow- derived precursors required at least heterozygous expression of the H- 2g7 haplotype on thymic epithelium, adolescent thymectomized (NOD x NON)F1 mice were implanted with neonatal NON/Lt thymus grafts before lethal radiation and reconstitution with NOD/Lt bone marrow. Peripheral T cells maturing through this ectopic thymic implant exclusively expressed the NOD H-2g7 haplotype and were tolerant to H-2nb1 skin grafts. Nevertheless, diabetes developed in 32% of the NON/Lt thymus- grafted chimeras vs 38% of the sham-thymectomized NOD bone marrow chimeras. Thus, homozygous expression of the diabetes-resistant H-2nb1 haplotype on thymic epithelium failed to block development of a diabetogenic T cell repertoire. To examine if expression of H-2nb1 on hemopoietically derived APC could alter the diabetogenic potential of NOD/Lt marrow, diabetes-resistant NOD.NON-H-2nb1 congenic mice were mated with NOD/Lt mice to produce NOD-H-2g7/H-2nb1 heterozygous recipients. These were lethally irradiated and reconstituted with either NOD/Lt marrow alone, NOD.H-2nb1 homozygous congenic marrow alone, or a 1:1 mixture of the two marrow populations. By 25 wk of age, all of the MHC heterozygous recipients of NOD.NON-H-2nb1 marrow remained diabetes-free whereas 75% of the MHC heterozygous recipients of NOD/Lt marrow developed diabetes. A striking decrease in diabetes was observed when T cell precursors derived from NOD/Lt marrow interacted with H-2nb1 gene products on hemopoietically derived APC, inasmuch as only 7% of the MHC heterozygous recipients reconstituted with a 1:1 mixture of NOD/Lt and NOD.NON-H-2nb1 marrow developed diabetes. Peripheral leukocytes in all reconstitution classes expressed the MHC phenotype(s) of the marrow donor(s). Skin grafting confirmed that all reconstitution classes of MHC heterozygous recipients were tolerant to the H-2nb1 haplotype.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
DiabetesHome page
Y.-G. Chen, P. A. Silveira, M. A. Osborne, H. D. Chapman, and D. V. Serreze
Cellular Expression Requirements for Inhibition of Type 1 Diabetes by a Dominantly Protective Major Histocompatibility Complex Haplotype
Diabetes, February 1, 2007; 56(2): 424 - 430.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. V. Serreze, M. A. Osborne, Y.-G. Chen, H. D. Chapman, T. Pearson, M. A. Brehm, and D. L. Greiner
Partial versus Full Allogeneic Hemopoietic Chimerization Is a Preferential Means to Inhibit Type 1 Diabetes as the Latter Induces Generalized Immunosuppression
J. Immunol., November 15, 2006; 177(10): 6675 - 6684.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Chen, Y.-G. Chen, P. C. Reifsnyder, W. H. Schott, C.-H. Lee, M. Osborne, F. Scheuplein, F. Haag, F. Koch-Nolte, D. V. Serreze, et al.
Targeted Disruption of CD38 Accelerates Autoimmune Diabetes in NOD/Lt Mice by Enhancing Autoimmunity in an ADP-Ribosyltransferase 2-Dependent Fashion.
J. Immunol., April 15, 2006; 176(8): 4590 - 4599.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C.-H. Lee, Y.-G. Chen, J. Chen, P. C. Reifsnyder, D. V. Serreze, M. Clare-Salzler, M. Rodriguez, C. Wasserfall, M. A. Atkinson, and E. H. Leiter
Novel Leptin Receptor Mutation in NOD/LtJ Mice Suppresses Type 1 Diabetes Progression: II. Immunologic Analysis
Diabetes, January 1, 2006; 55(1): 171 - 178.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-M. Choisy-Rossi, T. M. Holl, M. A. Pierce, H. D. Chapman, and D. V. Serreze
Enhanced Pathogenicity of Diabetogenic T Cells Escaping a Non-MHC Gene-Controlled Near Death Experience
J. Immunol., September 15, 2004; 173(6): 3791 - 3800.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Takaki, S. M. Lieberman, T. M. Holl, B. Han, P. Santamaria, D. V. Serreze, and T. P. DiLorenzo
Requirement for Both H-2Db and H-2Kd for the Induction of Diabetes by the Promiscuous CD8+ T Cell Clonotype AI4
J. Immunol., August 15, 2004; 173(4): 2530 - 2541.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. V. Serreze, T. M. Holl, M. P. Marron, R. T. Graser, E. A. Johnson, C. Choisy-Rossi, R. M. Slattery, S. M. Lieberman, and T. P. DiLorenzo
MHC Class II Molecules Play a Role in the Selection of Autoreactive Class I-Restricted CD8 T Cells That Are Essential Contributors to Type 1 Diabetes Development in Nonobese Diabetic Mice
J. Immunol., January 15, 2004; 172(2): 871 - 879.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
T. D. Zorina, V. M. Subbotin, S. Bertera, A. M. Alexander, C. Haluszczak, B. Gambrell, R. Bottino, A. J. Styche, and M. Trucco
Recovery of the Endogenous {beta} Cell Function in the NOD Model of Autoimmune Diabetes
Stem Cells, July 1, 2003; 21(4): 377 - 388.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Thiessen, P. Serra, A. Amrani, J. Verdaguer, and P. Santamaria
T-Cell Tolerance by Dendritic Cells and Macrophages as a Mechanism for the Major Histocompatibility Complex-Linked Resistance to Autoimmune Diabetes
Diabetes, February 1, 2002; 51(2): 325 - 338.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. A. Johnson, P. Silveira, H. D. Chapman, E. H. Leiter, and D. V. Serreze
Inhibition of Autoimmune Diabetes in Nonobese Diabetic Mice by Transgenic Restoration of H2-E MHC Class II Expression: Additive, But Unequal, Involvement of Multiple APC Subtypes
J. Immunol., August 15, 2001; 167(4): 2404 - 2410.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. V. Serreze, H. D. Chapman, C. M. Post, E. A. Johnson, W. L. Suarez-Pinzon, and A. Rabinovitch
Th1 to Th2 Cytokine Shifts in Nonobese Diabetic Mice: Sometimes an Outcome, Rather Than the Cause, of Diabetes Resistance Elicited by Immunostimulation
J. Immunol., January 15, 2001; 166(2): 1352 - 1359.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. E. Mathews, R. T. Graser, A. Savinov, D. V. Serreze, and E. H. Leiter
Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: Role for beta cell-expressed resistance determinants
PNAS, January 2, 2001; 98(1): 235 - 240.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Schmidt, A. Amrani, J. Verdaguer, S. Bou, and P. Santamaria
Autoantigen-Independent Deletion of Diabetogenic CD4+ Thymocytes by Protective MHC Class II Molecules
J. Immunol., April 15, 1999; 162(8): 4627 - 4636.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
W. M. Ridgway, H. Ito, M. Fasso, C. Yu, and C. Garrison Fathman
Analysis of the Role of  Variation of Major Histocompatibility Complex Class II Expression on Nonobese Diabetic (NOD) Peripheral T Cell Response
J. Exp. Med., December 21, 1998; 188(12): 2267 - 2275.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. V. Serreze, S. A. Fleming, H. D. Chapman, S. D. Richard, E. H. Leiter, and R. M. Tisch
B Lymphocytes Are Critical Antigen-Presenting Cells for the Initiation of T Cell-Mediated Autoimmune Diabetes in Nonobese Diabetic Mice
J. Immunol., October 15, 1998; 161(8): 3912 - 3918.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. V. Serreze, M. Bridgett, H. D. Chapman, E. Chen, S. D. Richard, and E. H. Leiter
Subcongenic Analysis of the Idd13 Locus in NOD/Lt Mice: Evidence for Several Susceptibility Genes Including a Possible Diabetogenic Role for {beta}2-Microglobulin
J. Immunol., February 1, 1998; 160(3): 1472 - 1478.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
D. Schmidt, J. Verdaguer, N. Averill, and P. Santamaria
A Mechanism for the Major Histocompatibility Complex-linked Resistance to Autoimmunity
J. Exp. Med., October 6, 1997; 186(7): 1059 - 1075.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. Thomas-Vaslin, D. Damotte, M. Coltey, N. M. Le Douarin, A. Coutinho, and J. Salaun
Abnormal T cell selection on nod thymic epithelium is sufficient to induce autoimmune manifestations in C57BL/6 athymic nude mice
PNAS, April 29, 1997; 94(9): 4598 - 4603.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.